Home > Call For Paper > CANCER BIOMARKERS

CANCER BIOMARKERS

Cancer biomarkers are substances or processes that indicate the presence of cancer in the body. They may be secreted by cancer cells or arise from the body’s response to cancer.
Sub-Sessions:  

  • Early Detection and Screening Biomarkers
  • Tumor-Specific Genetic Mutations and Alterations
  • Liquid Biopsy for Cancer Monitoring
  • Proteomics and Cancer Biomarkers
  • Immuno-Biomarkers for Cancer Immunotherapy
  • Epigenetic Biomarkers
  • MicroRNA Biomarkers
  • Exosomal Biomarkers
  • Tumor Microenvironment (TME) Biomarkers
  • Cancer Stem Cell (CSC) Biomarkers
  • Circulating Tumor DNA (ctDNA) as a Diagnostic Tool
  • Biomarkers for Tumor Aggressiveness and Prognosis
  • Biomarkers for Chemotherapy and Radiotherapy Response
  • Biomarkers for Resistance to Targeted Therapies
  • Multi-Omics Approaches to Cancer Biomarker Discovery
  • Biomarkers for Cancer Recurrence
  • Biomarkers in Rare and Undiagnosed Cancers
  • Cancer Risk Prediction Models Using Biomarkers
  • Cancer Biomarkers in Liquid Biopsy for Early Detection of Metastasis
  • Ethnic and Racial Disparities in Cancer Biomarkers

Related Tags: Diagnostic Biomarkers | Prognostic Biomarkers | Predictive Biomarkers | Liquid Biopsy | Tumor Markers | Molecular Diagnostics | Biomarker Discovery | Biomarker Validation | Companion Diagnostics | Personalized Medicine | Genomic Profiling | Proteomics | Transcriptomics | Immuno-oncology Biomarkers

Related Societies: Biomarkers Consortium | International Society for Biological Therapy of Cancer | Society for Biomarkers in Cancer | American Association for Cancer Research - Biomarkers Task Force | National Cancer Biomarkers Alliance

SUBMIT ABSTRACT
 +1-404-759-8307
Subscribe To Our Newsletter
409791
TOP